A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.

Oh, Do-Youn; Cha, Yongjun; Choi, In-Sil; Yoon, So-Young; Choi, In Keun; Kim, Jee Hyun; Oh, Sang Cheul; Kim, Chang Duck; Kim, Jae Sun; Bang, Yung-Jue; Kim, Yeul Hong

Oh, Do-Youn; Cha, Yongjun; Choi, In-Sil; Yoon, So-Young; Choi, In Keun; Kim, Jee Hyun; Oh, Sang Cheul; Kim, Chang Duck; Kim, Jae Sun; Bang, Yung-Jue; Kim, Yeul Hong.

Affiliation

Oh DY; Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea. ohdoyoun@snu.ac.kr

Cancer Chemother Pharmacol ; 65(3): 527-36, 2010 Feb.

Article in En | MEDLINE | ID: mdl-19578850

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Pancreatic Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Drug Combinations; Fatigue/chemically induced; Female; Humans; Kaplan-Meier Estimate; Leukopenia/chemically induced; Male; Middle Aged; Nausea/chemically induced; Neutropenia/chemically induced; Oxonic Acid/administration & dosage; Oxonic Acid/adverse effects; Pancreatic Neoplasms/pathology; Tegafur/administration & dosage; Tegafur/adverse effects; Treatment Outcome; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2010 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google